The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetes

2019 ◽  
Vol 23 (2) ◽  
pp. 161-170 ◽  
Author(s):  
Ruoqiong Cao ◽  
Hicret Islamoglu ◽  
Garrett Teskey ◽  
Karo Gyurjian ◽  
Rachel Abrahem ◽  
...  
Author(s):  
Vishwanath Venketaraman ◽  
Aram Yegiazaryan

Uncontrolled Type 2 diabetes is associated with altered metabolism resulting in microvascular and macrovascular diseases and enhanced susceptibility to Mycobacterium tuberculosis infection.


2020 ◽  
Author(s):  
Harindra D. Sathkumara ◽  
Karyna Hansen ◽  
Socorro Miranda-Hernandez ◽  
Brenda Govan ◽  
Catherine M. Rush ◽  
...  

AbstractComorbid type 2 diabetes poses a great challenge to the global control of tuberculosis. Here we assessed the efficacy of metformin (MET); an anti-diabetic drug, in mice infected with a very-low dose of Mycobacterium tuberculosis. In contrast to diabetic mice, infected non-diabetic mice that received the same therapeutic concentration of MET presented with significantly higher disease burden. This warrants further studies to investigate the disparate efficacy of MET against tuberculosis in diabetic and non-diabetic individuals.


2017 ◽  
Vol 186 ◽  
pp. 41-45 ◽  
Author(s):  
Sara Raposo-García ◽  
José Manuel Guerra-Laso ◽  
Silvia García-García ◽  
Javier Juan-García ◽  
Eduardo López-Fidalgo ◽  
...  

2020 ◽  
Vol 22 (8) ◽  
pp. 303-311 ◽  
Author(s):  
Mohammad Abdul Alim ◽  
Andreas Kupz ◽  
Suchandan Sikder ◽  
Catherine Rush ◽  
Brenda Govan ◽  
...  

2020 ◽  
Vol 65 (1) ◽  
pp. e01422-20
Author(s):  
Harindra D. Sathkumara ◽  
Karyna Hansen ◽  
Socorro Miranda-Hernandez ◽  
Brenda Govan ◽  
Catherine M. Rush ◽  
...  

ABSTRACTComorbid type 2 diabetes poses a great challenge to the global control of tuberculosis. Here, we assessed the efficacy of metformin (MET), an antidiabetic drug, in mice infected with a very low dose of Mycobacterium tuberculosis. In contrast to diabetic mice, infected nondiabetic mice that received the same therapeutic concentration of MET presented with significantly higher disease burden. This warrants further studies to investigate the disparate efficacy of MET against tuberculosis in diabetic and nondiabetic individuals.


AIDS ◽  
2015 ◽  
Vol 29 (2) ◽  
pp. 155-165 ◽  
Author(s):  
Christine E. Jones ◽  
Anneke C. Hesseling ◽  
Nontobeko G. Tena-Coki ◽  
Thomas J. Scriba ◽  
Novel N. Chegou ◽  
...  

Cell Reports ◽  
2019 ◽  
Vol 27 (9) ◽  
pp. 2649-2664.e5 ◽  
Author(s):  
Sulayman Benmerzoug ◽  
Badreddine Bounab ◽  
Stéphanie Rose ◽  
David Gosset ◽  
Franck Biet ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document